PremiumThe FlyAutonomix CEO outlines follow-on expansion study expected to begin in Q2 Autonomix releases testimonial of patient in trial of pancreatic cancer pain Autonomix provides update on initial phase on delivering transvascular energy PremiumThe FlyAutonomix engages advisors to guide clinical, regulatory path in cancer pain Autonomix granted U.S. patent for catheter-based technology Autonomix advances toward U.S. clinical trials in 2025 PremiumThe FlyAutonomix appoints Julie Manchester as VP, regulatory affairs, quality Autonomix achieves design lock for RF Ablation Catheter Autonomix to sell 1.38M units at $6.54 in underwritten public offering 
